297 related articles for article (PubMed ID: 31754997)
21. Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease.
Doria M; Maugest L; Moreau T; Lizard G; Vejux A
Free Radic Biol Med; 2016 Dec; 101():393-400. PubMed ID: 27836779
[TBL] [Abstract][Full Text] [Related]
22. Metals and Parkinson's Disease: Mechanisms and Biochemical Processes.
Bjorklund G; Stejskal V; Urbina MA; Dadar M; Chirumbolo S; Mutter J
Curr Med Chem; 2018; 25(19):2198-2214. PubMed ID: 29189118
[TBL] [Abstract][Full Text] [Related]
23. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
24. Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease.
Le Couteur DG; Muller M; Yang MC; Mellick GD; McLean AJ
Rev Environ Health; 2002; 17(1):51-64. PubMed ID: 12088093
[TBL] [Abstract][Full Text] [Related]
25. The role of transition metals in the pathogenesis of Parkinson's disease.
Kienzl E; Puchinger L; Jellinger K; Linert W; Stachelberger H; Jameson RF
J Neurol Sci; 1995 Dec; 134 Suppl():69-78. PubMed ID: 8847547
[TBL] [Abstract][Full Text] [Related]
26. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
27. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
29. SUMO-regulated mitochondrial function in Parkinson's disease.
Guerra de Souza AC; Prediger RD; Cimarosti H
J Neurochem; 2016 Jun; 137(5):673-86. PubMed ID: 26932327
[TBL] [Abstract][Full Text] [Related]
30. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management.
Phillipson OT
Ageing Res Rev; 2017 Nov; 40():149-167. PubMed ID: 28986235
[TBL] [Abstract][Full Text] [Related]
32. Phenothiazine normalizes the NADH/NAD
Tapias V; McCoy JL; Greenamyre JT
Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
Trist BG; Hare DJ; Double KL
Aging Cell; 2019 Dec; 18(6):e13031. PubMed ID: 31432604
[TBL] [Abstract][Full Text] [Related]
34. Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.
Haddad D; Nakamura K
FEBS Lett; 2015 Dec; 589(24 Pt A):3702-13. PubMed ID: 26526613
[TBL] [Abstract][Full Text] [Related]
35. Role of chemokines in Parkinson's disease.
Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH
Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787
[TBL] [Abstract][Full Text] [Related]
36. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein.
Vicario M; Cieri D; Vallese F; Catoni C; Barazzuol L; Berto P; Grinzato A; Barbieri L; Brini M; Calì T
Cell Death Dis; 2019 Nov; 10(11):857. PubMed ID: 31719530
[TBL] [Abstract][Full Text] [Related]
37. Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.
Kuter K; Kratochwil M; Marx SH; Hartwig S; Lehr S; Sugawa MD; Dencher NA
Arch Physiol Biochem; 2016 Dec; 122(5):238-256. PubMed ID: 27467289
[TBL] [Abstract][Full Text] [Related]
38. Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease.
Iglesias E; Pesini A; Garrido-Pérez N; Meade P; Bayona-Bafaluy MP; Montoya J; Ruiz-Pesini E
Ageing Res Rev; 2018 Aug; 45():24-32. PubMed ID: 29689408
[TBL] [Abstract][Full Text] [Related]
39. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
